Walther D

Designer Drug Research Unit, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, United States.

7 papers · 1 preprint

ArticleDMT

Synthesis and Biological Evaluation of 4‑Bromo-<i>N,N-</i>dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development.

Bray E, Glatfelter GC, Maitland AD +5

Europe PMC2026
ArticlePsychedelics

Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy-<i>N</i>-methyl-<i>N</i>-isopropyltryptamine and Related Analogs.

Glatfelter GC, Schalk SS, Walther D +9

Europe PMC2026
ArticleIbogaine

Deciphering Ibogaine's Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses.

Hwu C, Havel V, Westergaard X +20

Europe PMC2026
Article5-MeO-DMT

Rapid, Open-Source, and Automated Quantification of the Head Twitch Response in C57BL/6J Mice Using DeepLabCut and Simple Behavioral Analysis.

Maitland AD, Gonzalez NR, Walther D +3

Europe PMC2025
PreprintIbogaine

Deciphering Ibogaine’s Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses

Hwu C, Havel V, Westergaard X +18

Europe PMC2025
ArticleMDMA

Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine.

Johnson CB, Walther D, Baggott MJ +2

Europe PMC2024
ArticlePsilocybin

Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.

Glatfelter GC, Pham DNK, Walther D +4

Europe PMC2022
ArticleMDMA

(2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice.

Rudin D, McCorvy JD, Glatfelter GC +13

Europe PMC2022